D. R. Scott

发表

p53 polymorphism and risk of cervical cancer

David R. Scott, M. Carrington, J. Fraumeni, 1998, Nature.

Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.

M. Schiffman, P. Castle, A. Glass, 2007, Mutation research.

"ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection.

M. Sherman, M. Schiffman, R. Burk, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Cervical HPV DNA Detection as a Predictor of a Recurrent SIL Diagnosis Among Untreated Women

P. Castle, R. Burk, M. Schiffman, 2001, Journal of lower genital tract disease.

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

David R. Scott, S. Wacholder, M. Sherman, 2005, Journal of the National Cancer Institute.

A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study

David R. Scott, S. Wacholder, M. Sherman, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

David R. Scott, M. Carrington, M. Sherman, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer

David R. Scott, S. Wacholder, M. Sherman, 2003, Journal of Clinical Microbiology.

A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.

David R. Scott, S. Wacholder, M. Sherman, 2002, Journal of the National Cancer Institute.

Sexual Behavior, Human Papillomavirus Type 16 (HPV 16) Infection, and HPV 16 Seropositivity

M. Sherman, M. Schiffman, P. Castle, 2002, Sexually transmitted diseases.

Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.

David R. Scott, S. Wacholder, N. Wentzensen, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Viral load of human papillomavirus and risk of CIN3 or cervical cancer

David R. Scott, S. Wacholder, M. Sherman, 2002, The Lancet.

Determinants of Genital Human Papillomavirus Infection in Low‐Risk Women in Portland, Oregon

David R. Scott, M. Schiffman, A. Hildesheim, 1993, Sexually transmitted diseases.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

David R. Scott, S. Wacholder, M. Sherman, 2003, Journal of the National Cancer Institute.

Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom

David R. Scott, J. Cuzick, N. Kiviat, 2002, Cancer.

Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears

David R. Scott, M. Schiffman, M. Sherman, 2000, Cancer.

Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible

David R. Scott, M. Sherman, M. Schiffman, 2002, Journal of Clinical Microbiology.

Human papillomavirus prevalence in women who have and have not undergone hysterectomies.

S. Wacholder, P. Castle, R. Burk, 2006, The Journal of infectious diseases.

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

S Wacholder, David R. Scott, R. Hoover, 1993, Journal of the National Cancer Institute.

Improved Amplification of Genital Human Papillomaviruses

David R. Scott, C. Peyton, C. Wheeler, 2000, Journal of Clinical Microbiology.

Persistence of type-specific human papillomavirus infection among cytologically normal women.

David R. Scott, M. Sherman, M. Schiffman, 1994, The Journal of infectious diseases.

Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer

David R. Scott, S. Wacholder, M. Sherman, 2005, Cancer Epidemiology Biomarkers & Prevention.

Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens

David R. Scott, M. Sherman, M. Schiffman, 1997, Journal of clinical microbiology.

Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia.

David R. Scott, D. Lowy, M. Schiffman, 1995, The Journal of infectious diseases.

Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture

David R. Scott, N. Kiviat, M. Sherman, 1995, Journal of clinical microbiology.

Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.

David R. Scott, N. Kiviat, M. Sherman, 1994, American journal of clinical pathology.